Opinion|Videos|July 16, 2024

Long-Term Consequences of Untreated MGD

Author(s)Jessilin Quint, OD, MBA, MS, FAAO, Selina R. McGee, OD, FAAO, Dipl ABO

Experts on dry eye describe the potential long-term consequences for patients if MGD is left untreated.

Episodes in this series

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 1 Overview of MGD and Its Causes

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 2 Differentiating Aqueous vs Evaporative Dry Eye

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 3 Long-Term Consequences of Untreated MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 4 Factors to Consider in Treatment Selection for MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 5 Managing Evaporative Dry Eye with New FDA-Approved Therapy

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 6 Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 7 Combining In-Office and At-Home Therapies

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 8 Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

Video content above is prompted by the following question:

What are the potential long-term consequences for patients if MGD is left untreated?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related to this article

From Paper to Clinic, Episode 8: Dynamic Muscle Stimulation and the Blink Physiology Behind Dry Eye

November 2nd, 2026

From Paper to Clinic, Episode 9: Burnout in optometry and how to prevent it

Host Hamza Shah, OD, MS, FAAO, is joined by Melissa Barnett, OD, FAAO, FSLS, FBCLA, to discuss burnout among US optometrists, inspired by Abbott et al's nationwide survey.

Takeaways from this week in optometry | Image Credit: Canva

October 31st, 2026

Takeaways from this week in optometry: October 26-30

This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.

Eye drops | Image Credit: Adobe Stock/Dragana Gordic

October 30th, 2026

First genotype-guided dry eye trial, PREDICT-1, completes randomization

The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

The untapped partnership between retinal specialists and optometrists in myopia care

More magic in Anaheim: Highlights from AAOpt 2026

From our Editorial Board: Comments from the FDA Advisory Committee meeting on SYD-101

FDA approves ranibizumab biosimilar Lucamzi for wet AMD

Contact lens case hygiene among most skipped steps in lens care